scholarly journals Commercial Motor Vehicle Driver Obstructive Sleep Apnea Screening and Treatment in the United States: An Update and Recommendation Overview

2016 ◽  
Vol 12 (01) ◽  
pp. 113-125 ◽  
Author(s):  
Loretta J. Colvin ◽  
Nancy A. Collop
Keyword(s):  
United States ◽  
Obstructive Sleep Apnea ◽  
Sleep Apnea ◽  
Motor Vehicle ◽  
The United States ◽  
Obstructive Sleep ◽  
Commercial Motor Vehicle

scholarly journals Obstructive Sleep Apnea and Severe Maternal-Infant Morbidity/Mortality in the United States, 1998-2009

SLEEP ◽  
2014 ◽  
Vol 37 (5) ◽  
pp. 843-849 ◽  
Author(s):  
Judette M. Louis ◽  
Mulubrhan F. Mogos ◽  
Jason L. Salemi ◽  
Susan Redline ◽  
Hamisu M. Salihu
Keyword(s):  
United States ◽  
Obstructive Sleep Apnea ◽  
Sleep Apnea ◽  
The United States ◽  
Obstructive Sleep ◽  
Infant Morbidity

High risk of obstructive sleep apnea, insomnia, and daytime sleepiness among commercial motor vehicle drivers

2019 ◽  
Vol 23 (3) ◽  
pp. 979-985 ◽  
Author(s):  
Jun-Sang Sunwoo ◽  
Dae-Seop Shin ◽  
Young Hwangbo ◽  
Won-Joo Kim ◽  
Min Kyung Chu ◽  
...  
Keyword(s):  
Obstructive Sleep Apnea ◽  
Sleep Apnea ◽  
High Risk ◽  
Daytime Sleepiness ◽  
Motor Vehicle ◽  
Obstructive Sleep ◽  
Commercial Motor Vehicle ◽  
Commercial Motor Vehicle Drivers

scholarly journals Prevalence of Diagnosed Obstructive Sleep Apnea in the United States 2013-2016: Insured Patients Actively Seeking Care

2020 ◽  
Vol 3 (06) ◽  
pp. 478-486
Author(s):  
Joanna Suomi ◽  
Gregory Hess ◽  
Christine Won ◽  
Morgan Bron ◽  
John Acquavella
Keyword(s):  
United States ◽  
Obstructive Sleep Apnea ◽  
Sleep Apnea ◽  
Prevalence Ratio ◽  
The United States ◽  
Clinical Markers ◽  
Excessive Sleepiness ◽  
Pharmacy Claims ◽  
Obstructive Sleep ◽  
Age And Sex

Background: The prevalence of obstructive sleep apnea (OSA) has not been assessed within the United States (US) in over adecade. Objectives:From 2013 to 2016, we calculated annual 2-year limited duration prevalence of diagnosed OSA in a large (~66million), geographically diverse insured population. We evaluated trends by age and sex; and assessed positive airway pressure (PAP) use and excessive sleepiness (hypersomnia diagnosis, or prescriptions for stimulant or wake-promoting agent [WPA]). Methods:Overall and age/sex specific prevalence per 100 insured persons was calculated on an annual basis. The cohort was defined to include those with medical and pharmacy claims activity. To mitigate rule-out diagnoses,cases had to have ≥2 medical claims for OSA within a 6-month period. Overall annual prevalences were directly standardized to the US population using 2016 US age and sex Census weights. Results: Annualage/sex adjusted prevalence of OSA increased from 2.4% in 2013 to 3.4% in 2016. OSA patients had a mean age of 58 years and there was a ≈2:1 male:female prevalence ratio. OSA patients with PAP claims increased from 42.2% to 44.1% over the study period. Excessive sleepiness (hypersomnia or stimulant/WPA prescriptions) for patients with or without PAP use both declined by ≈ 4% -5%. Conclusions:Diagnosed OSA prevalence and PAP use among insured members with claims activity increased during 2013-2016 while clinical markers of excessive sleepiness declined.   Males had a much higher prevalence of OSA than females.

scholarly journals Obstructive Sleep Apnea and Driving: A Canadian Thoracic Society and Canadian Sleep Society Position Paper

2014 ◽  
Vol 21 (2) ◽  
pp. 114-123 ◽  
Author(s):  
Najib Ayas ◽  
Robert Skomro ◽  
Adam Blackman ◽  
Kristen Curren ◽  
Michael Fitzpatrick ◽  
...  
Keyword(s):  
Obstructive Sleep Apnea ◽  
Sleep Apnea ◽  
Working Group ◽  
Motor Vehicle ◽  
The United States ◽  
Commercial Vehicles ◽  
Fitness To Drive ◽  
Obstructive Sleep ◽  
Increased Risk ◽  
Renewal Period

Individuals with obstructive sleep apnea (OSA) experience sleep fragmentation and poor sleep quality that results in daytime sleepiness, which impairs performance during driving and leads to an increased risk for collisions. Not surprisingly, observational studies have shown that patients with OSA experience a two- to 10-fold higher risk for collision compared with healthy controls. Although treatment would clearly mitigate these risks, there is no current Canadian position on driving and OSA. This article, the first Canadian position statement addressing the issue, provides an overview of provincial regulations and proposes recommendations with regard to driving in patients with OSA.Untreated patients with obstructive sleep apnea (OSA) are at increased risk for motor vehicle collisions; however, it is unclear how this should be translated into fitness-to-drive recommendations. Accordingly, the Canadian Thoracic Society (CTS) Sleep Disordered Breathing Clinical Assembly and the Canadian Sleep Society (CSS) assembled a CTS-CSS working group to propose recommendations with regard to driving in patients with OSA.Recommendations for assessing fitness to drive in noncommercial drivers: 1. Severity of OSA alone is not a reliable predictor of collision risk and, therefore, should not be used in isolation to assess fitness to drive; 2. The severity of sleep apnea should be considered in the context of other factors to assess fitness to drive; 3. The decision to restrict driving is ultimately made by the motor vehicle licensing authority; however, they should take into account the information and recommendations provided by the sleep medicine physician and should follow provincial guidelines; 4. For patients prescribed continuous positive airway pressure (CPAP) therapy, objective CPAP compliance should be documented. Efficacy should also be documented in terms of reversing the symptoms and improvement in sleep apnea based on physiological monitoring; 5. For patients treated with surgery or an oral appliance, verification of adequate sleep apnea treatment should be obtained; and 6. A driver diagnosed with OSA may be recertified as fit to drive based on assessment of symptoms and demonstrating compliance with treatment. The assessment should be aligned with the provincial driver’s license renewal period.Commercial vehicles: Assessment of fitness to drive should be more stringent for patients operating commercial vehicles. In general, the CTS-CSS working group was in agreement with the Medical Expert Panel recommendations to the Federal Motor Carrier Safety Administration in the United States; these recommendations were adapted for Canadian practitioners.

Sign in / Sign up

Export Citation Format

Share Document